Financial Metrics Exploration: Understanding Zai Lab Limited ADR (ZLAB) Through Ratios

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

The closing price of Zai Lab Limited ADR (NASDAQ: ZLAB) was $28.93 for the day, down -4.76% from the previous closing price of $30.38. In other words, the price has decreased by -$4.76 from its previous closing price. On the day, 1.29 million shares were traded. ZLAB stock price reached its highest trading level at $29.645 during the session, while it also had its lowest trading level at $28.39.

Ratios:

Our analysis of ZLAB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.38 and its Current Ratio is at 3.51. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.02.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $55.

On March 03, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $29 to $36.10.

On December 14, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $47.50.Morgan Stanley initiated its Overweight rating on December 14, 2023, with a $47.50 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 04 ’25 when Smiley Joshua L sold 3,354 shares for $33.11 per share. The transaction valued at 111,044 led to the insider holds 67,345 shares of the business.

Edmondson Frazor Titus III sold 1,874 shares of ZLAB for $62,044 on Apr 04 ’25. The Chief Legal Officer now owns 30,375 shares after completing the transaction at $33.11 per share. On Apr 04 ’25, another insider, Du Ying, who serves as the Chairperson & CEO of the company, sold 2,945 shares for $33.11 each. As a result, the insider received 97,503 and left with 479,851 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 3264562432 and an Enterprise Value of 30503438336. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.95 while its Price-to-Book (P/B) ratio in mrq is 3.71. Its current Enterprise Value per Revenue stands at 76.452 whereas that against EBITDA is -112.867.

Stock Price History:

The Beta on a monthly basis for ZLAB is 1.06, which has changed by 1.0348101 over the last 52 weeks, in comparison to a change of 0.05279863 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $39.77, while it has fallen to a 52-week low of $13.48. The 50-Day Moving Average of the stock is -12.03%, while the 200-Day Moving Average is calculated to be 11.26%.

Shares Statistics:

ZLAB traded an average of 1.16M shares per day over the past three months and 2153700 shares per day over the past ten days. A total of 109.64M shares are outstanding, with a floating share count of 108.60M. Insiders hold about 0.94% of the company’s shares, while institutions hold 50.89% stake in the company. Shares short for ZLAB as of 1743379200 were 7323782 with a Short Ratio of 6.31, compared to 1740700800 on 7828888. Therefore, it implies a Short% of Shares Outstanding of 7323782 and a Short% of Float of 7.7.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular